Breast MRI: EUSOBI recommendations for women’s information

European Radiology

Volumn 25, Issue 12, 2015, Pages 3669-3678

  Mann, Ritse M ^a   Balleyguier, Corinne ^b   Baltzer, Pascal A ^c   Bick, Ulrich ^d   Colin, Catherine ^e   Cornford, Eleanor ^f   Evans, Andrew ^g   Fallenberg, Eva ^d   Forrai, Gabor ^h   Fuchsjäger, Michael H ⁱ   Gilbert, Fiona J ^j   Helbich, Thomas H ^c   Heywang Köbrunner, Sylvia H ^k   Camps Herrero, Julia ^l   Kuhl, Christiane K ^m   Martincich, Laura ⁿ   Pediconi, Federica ^o   Panizza, Pietro ^p   Pina, Luis J ^q   Pijnappel, Ruud M ^r   Pinker Domenig, Katja ^c   Skaane, Per ^s   Sardanelli, Francesco ^t   more..

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e CENTRE HOSPITALIER LYON SUD   (France)

^f NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^g UNIVERSITY OF DUNDEE   (United Kingdom)

^h SEMMELWEIS UNIVERSITY   (Hungary)

ⁱ MEDICAL UNIVERSITY OF GRAZ   (Austria)

^j UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^k Munich   (Germany)

^l HOSPITAL DE LA RIBERA   (Spain)

^m UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

ⁿ FPO IRCCS   (Italy)

^o SAPIENZA UNIVERSITY OF ROME   (Italy)

^p NATIONAL CANCER INSTITUTE   (Italy)

^q UNIVERSITY CLINIC OF NAVARRA   (Spain)

^r UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^s ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^t UNIVERSITY OF MILAN   (Italy)

more..

Author keywords

Access to information; Breast; Breast cancer; Magnetic resonance imaging; Patient advocacy

Indexed keywords

ANTINEOPLASTIC AGENT;

ACCESS TO INFORMATION; ARTICLE; BENIGN TUMOR; BREAST CANCER; BREAST EXAMINATION; BREAST IMPLANT; BREAST MAGNETIC RESONANCE IMAGING; CANCER ADJUVANT THERAPY; CANCER SCREENING; CANCER STAGING; CLINICAL EVALUATION; DISEASE CLASSIFICATION; DOCTOR PATIENT RELATION; DRUG EFFECT; FALSE POSITIVE RESULT; FAMILY HISTORY; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTERPERSONAL COMMUNICATION; MAMMOGRAPHY; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; PALPATION; PATIENT CARE; PATIENT SAFETY; PATIENT SCHEDULING; PREOPERATIVE PERIOD; PRIMARY TUMOR; PRIORITY JOURNAL; PROBLEM SOLVING; RADIOLOGICAL PARAMETERS; BREAST; BREAST NEOPLASMS; EUROPE; PATHOLOGY; PRACTICE GUIDELINE; PROCEDURES;

BREAST; BREAST NEOPLASMS; EUROPE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINES AS TOPIC;

EID: 84946492061     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-015-3807-z     Document Type: Article

References (62)

1. Heywang SH, Hahn D, Schmidt H et al (1986) MR imaging of the breast using gadolinium-DTPA. J Comput Assist Tomogr 10:199–204
2. Kaiser WA, Zeitler E (1989) MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. Radiology 170:681–686
3. Kuhl C (2007) The current status of breast MR imaging. Part I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology 244:356–378
4. Turnbull LW (2009) Dynamic contrast-enhanced MRI in the diagnosis and management of breast cancer. NMR Biomed 22:28–39
5. Kuhl CK (2007) Current status of breast MR imaging. Part 2. Clinical applications. Radiology 244:672–691
6. Mann RM, Kuhl CK, Kinkel K, Boetes C (2008) Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol 18:1307–1318
7. Sardanelli F, Boetes C, Borisch B et al (2010) Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer 46:1296–1316
8. Scheurlen K, Schnitzer A, Krammer J, et al (2014) Value of galactography for the diagnostic work-up of pathological nipple discharge in multimodal breast diagnostics: Part 2: a systematic review of the literature. Radiologe 54:160–166
9. Londero V, Zuiani C, Linda A et al (2012) High-risk breast lesions at imaging-guided needle biopsy: usefulness of MRI for treatment decision. AJR Am J Roentgenol 199:W240–W250
10. Sardanelli F, Helbich T, for the European Society of Breast Imaging (EUSOBI) (2012) Mammography: EUSOBI recommendations for women’s information. Insights Imaging 3:7–10
11. Eshed I, Althoff CE, Hamm B, Hermann KG (2007) Claustrophobia and premature termination of magnetic resonance imaging examinations. J Magn Reson Imaging 26:401–404
12. Institute for magnetic resonance safety, education, and research. At: http://www.mrisafety.com/. Accessed on 22 Aug 2014
13. Thomsen HS, Morcos SK, Almen T et al (2013) Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol 23:307–318
14. Cova MA, Stacul F, Quaranta R et al (2014) Radiological contrast media in the breastfeeding woman: a position paper of the Italian Society of Radiology (SIRM), the Italian Society of Paediatrics (SIP), the Italian Society of Neonatology (SIN) and the Task Force on Breastfeeding, Ministry of Health, Italy. Eur Radiol 24:2012–2022
15. Kuhl CK, Bieling HB, Gieseke J et al (1997) Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology 203:137–144
16. Delille JP, Slanetz PJ, Yeh ED, Kopans DB, Garrido L (2005) Physiologic changes in breast magnetic resonance imaging during the menstrual cycle: perfusion imaging, signal enhancement, and influence of the T1 relaxation time of breast tissue. Breast J 11:236–241
17. Baltzer PA, Dietzel M, Vag T et al (2011) Clinical MR mammography: impact of hormonal status on background enhancement and diagnostic accuracy. Röfo 183:441–447
18. DeMartini WB, Liu F, Peacock S et al (2012) Background parenchymal enhancement on breast MRI: impact on diagnostic performance. AJR Am J Roentgenol 198:W373–W380
19. Kajihara M, Goto M, Hirayama Y et al (2013) Effect of the menstrual cycle on background parenchymal enhancement in breast MR imaging. Magn Reson Med Sci 12:39–45
20. Ellis RL (2009) Optimal timing of breast MRI examinations for premenopausal women who do not have a normal menstrual cycle. AJR Am J Roentgenol 193:1738–1740
21. Hegenscheid K, Schmidt CO, Seipel R et al (2012) Contrast enhancement kinetics of normal breast parenchyma in dynamic MR mammography: effects of menopausal status, oral contraceptives, and postmenopausal hormone therapy. Eur Radiol 22:2633–2640
22. American College of Radiology (ACR) Breast Imaging Reporting and Data System Atlas (BI-RADS Atlas). Reston, Va, U.S.A.: American College of Radiology; 2013. At: http://www.acr.org/Quality-Safety/Resources/BIRADS/MRI. Accessed on 21 Aug 2014
23. Pinker-Domenig K, Bogner W, Gruber S et al (2012) High resolution MRI of the breast at 3 T: which BI-RADS® descriptors are most strongly associated with the diagnosis of breast cancer? Eur Radiol 22:322–330
24. Spick C, Baltzer PA (2014) Diagnostic utility of second-Look US for breast lesions identified at MR imaging: systematic review and meta-analysis. Radiology 273:401–409
25. Heywang-Köbrunner SH, Sinnatamby R, Consensus Group et al (2009) Interdisciplinary consensus on the uses and technique of MR-guided vacuum-assisted breast biopsy (VAB): results of a European consensus meeting. Eur J Radiol 72:289–294
26. Smith H, Chetlen AL, Schetter S et al (2014) PPV(3) of suspicious breast MRI findings. Acad Radiol 21:1553–1562
27. Comstock C, Sung JS (2013) BI-RADS 3 for magnetic resonance imaging. Magn Reson Imaging Clin N 21:561–570
28. Spick C, Szolar DH, Baltzer PA et al (2014) Rate of malignancy in MRI-detected probably benign (BI-RADS 3) lesions. AJR Am J Roentgenol 202:684–689
29. Liberman L, Morris EA, Benton CL, Abramson AF, Dershaw DD (2003) Probably benign lesions at breast magnetic resonance imaging: preliminary experience in high-risk women. Cancer 98:377–388
30. Neubauer H, Li M, Kuehne-Heid R, Schneider A, Kaiser WA (2003) High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement. Br J Radiol 76:3–12
31. Kuhl CK, Schrading S, Bieling HB et al (2007) MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 370:485–492
32. Facius M, Renz DM, Neubauer H et al (2007) Characteristics of ductal carcinoma in situ in magnetic resonance imaging. Clin Imaging 31:394–400
33. Dorrius MD, Pijnappel RM, der Jansen-van Weide MC, Oudkerk M (2010) Breast magnetic resonance imaging as a problem-solving modality in mammographic BI-RADS 3 lesions. Cancer Imaging 10:S54–S58
34. Saslow D, Boetes C, Burke W et al (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57:75–89
35. Lord SJ, Lei W, Craft P et al (2007) A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer 43:1905–1917
36. Warner E, Messersmith H, Causer P et al (2008) Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 148:671–679
37. Riedl CC, Ponhold L, Flory D et al (2007) Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer. Clin Cancer Res 13:6144–6152
38. Kuhl C, Weigel S, Schrading S et al (2010) Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol 28:1450–1457
39. Sardanelli F, Podo F, Santoro F et al (2011) Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results. Invest Radiol 46:94–105
40. Taneja C, Edelsberg J, Weycker D et al (2009) Cost-effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women. J Am Coll Radiol 6:171–179
41. Sung JS, Lee CH, Morris EA, Oeffinger KC, Dershaw DD (2011) Screening breast MR imaging in women with a history of chest irradiation. Radiology 259:65–71
42. Ng AK, Garber JE, Diller LR et al (2013) Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma. J Clin Oncol 31:2282–2288
43. Tieu MT, Cigsar C, Ahmed S (2014) Breast cancer detection among young survivor of pediatric Hodgkin lymphoma with screening magnetic resonance imaging. Cancer 120:2507–2513
44. Phi XA, Houssami N, Obdeijn IM et al (2015) Magnetic resonance imaging improves breast screening Sensitivity in BRCA Mutation Carriers Age ≥ 50 Years: Evidence From an Individual Patient Data Meta-Analysis. J Clin Oncol 33:349–356
45. Turnbull L, Brown S, Harvey I et al (2010) Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 375:563–571
46. Peters NH, van Esser S, van den Bosch MA et al (2011) Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET - randomised controlled trial. Eur J Cancer 47:879–886
47. Sakakibara M, Nagashima T, Sangai T et al (2008) Breast-conserving surgery using projection and reproduction techniques of surgical-position breast MRI in patients with ductal carcinoma in situ of the breast. J Am Coll Surg 207:62–68
48. Gonzalez V, Sandelin K, Karlsson A et al (2014) Preoperative MRI of the breast (POMB) influences primary treatment in breast cancer: a prospective, randomized, multicenter study. World J Surg 38:1685–1693
49. Mann RM, Loo CE, Wobbes T et al (2010) The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast. Breast Cancer Res Treat 119:415–422
50. Houssami N, Turner R, Morrow M (2013) Preoperative magnetic resonance imaging in breast cancer: meta-analysis of surgical outcomes. Ann Surg 257:249–255
51. Di Leo G, Trimboli RM, Benedek A et al (2015) Magnetic resonance imaging for selecting patients for partial breast irradiation: a systematic review and meta-analysis. Radiology. doi:10.1148/radiol.2015142508
52. Holland R, Veling SH, Mravunac M, Hendriks JH (1985) Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 56:979–990
53. Plana MN, Carreira C, Muriel A et al (2012) Magnetic resonance imaging in the preoperative assessment of patients with primary breast cancer: systematic review of diagnostic accuracy and meta-analysis. Eur Radiol 22:26–38
54. Pediconi F, Catalano C, Roselli A et al (2007) Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions. Radiology 243:670–680
55. Hartman M, Czene K, Reilly M et al (2007) Incidence and prognosis of synchronous and metachronous bilateral breast cancer. J Clin Oncol 25:4210–4216
56. Robertson C, Arcot Ragupathy SK, Boachie C et al (2011) The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews registry database analyses and economic evaluation. Health Technol Assess 15:v-322
57. Hold PM, Alam S, Pilbrow WJ et al (2012) How should we investigate breast implant rupture? Breast J 18:253–256
58. Brown SL, Middleton MS, Berg WA, Soo MS, Pennello G (2000) Prevalence of rupture of silicone gel breast implants revealed on MR imaging in a population of women in Birmingham, Alabama. AJR Am J Roentgenol 175:1057–1064
59. Marinovich ML, Sardanelli F, Ciatto S et al (2012) Early prediction of pathologic response to neoadjuvant therapy in breast cancer: systematic review of the accuracy of MRI. Breast 21:669–677
60. Marinovich ML, Houssami N, Macaskill P et al (2013) Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy. J Natl Cancer Inst 105:321–333
61. Marinovich ML, Macaskill P, Irwig L et al (2013) Meta-analysis of agreement between MRI and pathologic breast tumour size after neoadjuvant chemotherapy. Br J Cancer 109:1528–1536
62. Lu H, Xu YL, Zhang SP et al (2011) Breast magnetic resonance imaging in patients with occult breast carcinoma: evaluation on feasibility and correlation with histopathological findings. Chin Med J (Engl) 124:1790–1795